Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Metabolic Aspects of Anthracycline Cardiotoxicity
Michele Russo, Angela Della Sala, Carlo G. Tocchetti, et al.
Current Treatment Options in Oncology (2021) Vol. 22, Iss. 2
Open Access | Times Cited: 74

Showing 26-50 of 74 citing articles:

The Role of Mitochondrial Quality Control in Anthracycline-Induced Cardiotoxicity: From Bench to Bedside
Yukun Li, Rong Lin, Xiaodong Peng, et al.
Oxidative Medicine and Cellular Longevity (2022) Vol. 2022, pp. 1-22
Open Access | Times Cited: 17
The dual role of ferroptosis in anthracycline-based chemotherapy includes reducing resistance and increasing toxicity
Jiazheng Zhao, Ning Zhang, Xiaowei Ma, et al.
Cell Death Discovery (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 10
Role of gut microbiota in doxorubicin-induced cardiotoxicity: from pathogenesis to related interventions
Chao Huang, Xiaoxia Li, Hanqing Li, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 3
Cardiac Slc25a49‐Mediated Energy Reprogramming Governs Doxorubicin‐Induced Cardiomyopathy through the G6P–AP‐1–Sln Axis
Sitong Wan, Jingyi Qi, Yi Xia, et al.
Advanced Science (2025)
Open Access
The Interplay Between Autophagy and Senescence in Anthracycline Cardiotoxicity
Michele Russo, Enrico Bono, Alessandra Ghigo
Current Heart Failure Reports (2021) Vol. 18, Iss. 4, pp. 180-190
Open Access | Times Cited: 22
MicroRNAs in doxorubicin-induced cardiotoxicity: The DNA damage response
Ippei Kawano, Michaela Adamcová
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 15
Molecular mechanism of empagliflozin cardioprotection in 5-fluorouracil (5-FU)-induced cardiotoxicity via modulation of SGLT2 and TNFα/TLR/NF-κB signaling pathway in rats
Marwa M. M. Refaie, Sayed Shehata, Maram El‐Hussieny, et al.
Toxicological Research (2023) Vol. 40, Iss. 1, pp. 139-151
Open Access | Times Cited: 9
CardioMotion: identification of functional and structural cardiotoxic liabilities in small molecules through brightfield kinetic imaging
W. Stebbeds, Kavita Raniga, David Standing, et al.
Toxicological Sciences (2023) Vol. 195, Iss. 1, pp. 61-70
Open Access | Times Cited: 8
Anthracycline-induced cardiotoxicity: targeting high-density lipoproteins to limit the damage?
Carmelita Abrahams, Nicholas J. Woudberg, Sandrine Lecour
Lipids in Health and Disease (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 14
Neurotoxic Effect of Doxorubicin Treatment on Cardiac Sympathetic Neurons
Nicola Moro, Lolita Dokshokova, Induja Perumal Vanaja, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 19, pp. 11098-11098
Open Access | Times Cited: 13
Exercise Interventions for the Prevention and Treatment of Anthracycline-Induced Cardiotoxicity in Women with Breast Cancer: A Systematic Review
Hongmei Li, Haiyun Liu, Boliang Wang, et al.
Journal of Science in Sport and Exercise (2024)
Open Access | Times Cited: 2
Co-morbid intersections of cancer and cardiovascular disease and targets for natural drug action: Reprogramming of lipid metabolism
Guanghui Zhu, Luchang Cao, Jingyuan Wu, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 176, pp. 116875-116875
Open Access | Times Cited: 2
Inflammation in cardio-oncology: beyond immunotherapies
Anne Lise Ferrara, Stefania Loffredo, Carlo G. Tocchetti
European Heart Journal (2024) Vol. 45, Iss. 25, pp. 2251-2253
Open Access | Times Cited: 2
Anticancer potential of active alkaloids and synthetic analogs derived from marine invertebrates
Chunyan Cai, Dejun Yang, Yi Cao, et al.
European Journal of Medicinal Chemistry (2024) Vol. 279, pp. 116850-116850
Closed Access | Times Cited: 2
Modeling Doxorubicin-Induced Cardiomyopathy With Fibrotic Myocardial Damage in Wistar Rats
Ekaterina Podyacheva, Т. В. Шмакова, Е. А. Кушнарева, et al.
Cardiology Research (2022) Vol. 13, Iss. 6, pp. 339-356
Open Access | Times Cited: 10
Generation of a p21 Reporter Mouse and Its Use to Identify and Eliminate p21high Cells In Vivo
Zimei Yi, Ren Le, Yu Wei, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 6, pp. 5565-5565
Open Access | Times Cited: 6
Identification of the metabolic state of surviving cardiomyocytes in the human infarcted heart by spatial single-cell transcriptomics
Yan Shen, Il‐man Kim, Neal L. Weintraub, et al.
Cardiology Plus (2023)
Open Access | Times Cited: 6
Racial Disparity in Anthracycline-induced Cardiotoxicity in Breast Cancer Patients
Swetha Balaji, Antu K. Antony, Harry Tonchev, et al.
Biomedicines (2023) Vol. 11, Iss. 8, pp. 2286-2286
Open Access | Times Cited: 6
Cardiac Imaging in Childhood Cancer Survivors: A State-of-the-Art Review
Massimiliano Camilli, Roderick Skinner, Giulia Iannaccone, et al.
Current Problems in Cardiology (2022) Vol. 48, Iss. 4, pp. 101544-101544
Closed Access | Times Cited: 8
Anthracyclines and trastuzumab associated cardiotoxicity: is the gut microbiota a friend or foe? – a mini-review
J. Guilherme Gonçalves-Nobre, Inês Gaspar, Diogo Alpuim Costa
Frontiers in Microbiomes (2023) Vol. 2
Open Access | Times Cited: 4
Predicting oncology drug-induced cardiotoxicity with donor-specific iPSC-CMs—a proof-of-concept study with doxorubicin
Li Pang, Chengzhong Cai, Praful Aggarwal, et al.
Toxicological Sciences (2024) Vol. 200, Iss. 1, pp. 79-94
Open Access | Times Cited: 1
Prediabetes is associated with increased cardiac events in patients with cancer who are prescribed anthracyclines
Iokfai Cheang, Xu Zhu, Jiayi Huang, et al.
Cancer (2024) Vol. 130, Iss. 16, pp. 2795-2806
Open Access | Times Cited: 1
Cardiac Atrophy, Dysfunction, and Metabolic Impairments
Leslie M. Ogilvie, Luca J. Delfinis, Bridget Coyle‐Asbil, et al.
American Journal Of Pathology (2024) Vol. 194, Iss. 10, pp. 1823-1843
Closed Access | Times Cited: 1
The Current State of Realistic Heart Models for Disease Modelling and Cardiotoxicity
Kornél Kistamás, Federica Lamberto, Raminta Vaičiulevičiūtė, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 17, pp. 9186-9186
Open Access | Times Cited: 1
Fasting: A Complex, Double-Edged Blade in the Battle Against Doxorubicin-Induced Cardiotoxicity
Yiming Meng, Jing Sun, Guirong Zhang, et al.
Cardiovascular Toxicology (2024)
Closed Access | Times Cited: 1

Scroll to top